跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VAQTA hepatitis A vaccine inactivated 50 units/1mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
VAQTA hepatitis A vaccine inactivated 50 units/1mL injection vial
Approved
STANDARD
VAQTA hepatitis A vaccine inactivated 50 units/1mL injection vial
Merck Sharp & Dohme (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
42215afd50822cc0
Company
Merck Sharp & Dohme (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
42215afd50822cc0
Product Name
VAQTA hepatitis A vaccine inactivated 50 units/1mL injection vial
Artg Id
58536
Artg Name
VAQTA hepatitis A vaccine inactivated 50 units/1mL injection vial
Sponsor
Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path
/organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date
1997-01-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a11979609e6752727b8dd9c07cd550a3.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c9e1a01955824b39f2d377b9c50e8959.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
42215afd50822cc0
Type
Standard
Back to TGA Approvals